115 related articles for article (PubMed ID: 23851497)
1. Cytoplasmic interaction of the tumour suppressor protein hSNF5 with dynamin-2 controls endocytosis.
Alfonso-Pérez T; Domínguez-Sánchez MS; García-Domínguez M; Reyes JC
Oncogene; 2014 Jun; 33(23):3064-74. PubMed ID: 23851497
[TBL] [Abstract][Full Text] [Related]
2. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
[TBL] [Abstract][Full Text] [Related]
3. Integrase interactor 1 in health and disease.
Das S
Curr Protein Pept Sci; 2015; 16(6):478-90. PubMed ID: 25772157
[TBL] [Abstract][Full Text] [Related]
4. Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.
Boese A; Sommer P; Holzer D; Maier R; Nehrbass U
J Gen Virol; 2009 Oct; 90(Pt 10):2503-2512. PubMed ID: 19515827
[TBL] [Abstract][Full Text] [Related]
5. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters.
Kuwahara Y; Wei D; Durand J; Weissman BE
Mol Cancer Res; 2013 Mar; 11(3):251-60. PubMed ID: 23364536
[TBL] [Abstract][Full Text] [Related]
6. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.
Versteege I; Medjkane S; Rouillard D; Delattre O
Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744
[TBL] [Abstract][Full Text] [Related]
7. RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.
Caramel J; Quignon F; Delattre O
Cancer Res; 2008 Aug; 68(15):6154-61. PubMed ID: 18676838
[TBL] [Abstract][Full Text] [Related]
8. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
Caramel J; Medjkane S; Quignon F; Delattre O
Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.
Wu DY; Kalpana GV; Goff SP; Schubach WH
J Virol; 1996 Sep; 70(9):6020-8. PubMed ID: 8709224
[TBL] [Abstract][Full Text] [Related]
10. Generation of a monoclonal antibody for INI1/hSNF5/BAF47.
Harada A; Hayashi M; Kuniyoshi Y; Semba Y; Sugahara S; Tachibana T; Ohkawa Y; Fujita M
Monoclon Antib Immunodiagn Immunother; 2014 Feb; 33(1):49-51. PubMed ID: 24555937
[TBL] [Abstract][Full Text] [Related]
11. The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells.
Albanese P; Belin MF; Delattre O
Eur J Cancer; 2006 Sep; 42(14):2326-34. PubMed ID: 16908131
[TBL] [Abstract][Full Text] [Related]
12. [BEX2 regulates cell cycle through the interaction with INI1/hSNF5].
Han QY; Fan YH; Wang YL; Zhang SD; Han CY
Yi Chuan; 2012 Jun; 34(6):711-8. PubMed ID: 22698742
[TBL] [Abstract][Full Text] [Related]
13. Chromatin-remodeling factor INI1/hSNF5/BAF47 is involved in activation of the colony stimulating factor 1 promoter.
Pan X; Song Z; Zhai L; Li X; Zeng X
Mol Cells; 2005 Oct; 20(2):183-8. PubMed ID: 16267391
[TBL] [Abstract][Full Text] [Related]
14. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.
Cheng SW; Davies KP; Yung E; Beltran RJ; Yu J; Kalpana GV
Nat Genet; 1999 May; 22(1):102-5. PubMed ID: 10319872
[TBL] [Abstract][Full Text] [Related]
15. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA.
Lee D; Sohn H; Kalpana GV; Choe J
Nature; 1999 Jun; 399(6735):487-91. PubMed ID: 10365963
[TBL] [Abstract][Full Text] [Related]
16. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB.
Betz BL; Strobeck MW; Reisman DN; Knudsen ES; Weissman BE
Oncogene; 2002 Aug; 21(34):5193-203. PubMed ID: 12149641
[TBL] [Abstract][Full Text] [Related]
17. Characterization of DNA binding property of the HIV-1 host factor and tumor suppressor protein Integrase Interactor 1 (INI1/hSNF5).
Das S; Banerjee B; Hossain M; Thangamuniyandi M; Dasgupta S; Chongdar N; Kumar GS; Basu G
PLoS One; 2013; 8(7):e66581. PubMed ID: 23861745
[TBL] [Abstract][Full Text] [Related]
18. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
[TBL] [Abstract][Full Text] [Related]
19. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.
Grand F; Kulkarni S; Chase A; Goldman JM; Gordon M; Cross NC
Cancer Res; 1999 Aug; 59(16):3870-4. PubMed ID: 10463572
[TBL] [Abstract][Full Text] [Related]
20. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors.
DeCristofaro MF; Betz BL; Wang W; Weissman BE
Oncogene; 1999 Dec; 18(52):7559-65. PubMed ID: 10602515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
